Editorial: Diagnosis and treatment of non-functioning pituitary tumors. [PDF]
Sav A.
europepmc +1 more source
ACTH bioassay with isolated rat adrenal cells: ACTH activity of the porcins lipotropic peptide B [PDF]
Baur, X. +5 more
core +1 more source
Early adversity and the comorbidity between metabolic disease and psychopathology
Abstract figure legend Hierarchical diagram representing the interplay between the genetic background and early life adversities and its effect on multiple physiological processes that ultimately impact on the risk for the comorbdity between psychopathology and cardiometabolic disorders.
Ameyalli Gómez‐Ilescas +1 more
wiley +1 more source
68Ga-DOTATOC PET/CT in the Localization of Pituitary Tumors in Cushing's Disease. [PDF]
Kim K +9 more
europepmc +1 more source
Intramuscular pathways of maladaptation in overtraining syndrome
Abstract figure legend The transition from adaptive overreaching to maladaptive overtraining and mechanisms through which excessive training load can lead to performance decline. Four interconnected pathophysiological domains are highlighted: neural fatigue, involving both central and peripheral components such as altered sensory feedback and reflex ...
Emily Shorter +4 more
wiley +1 more source
A Bridge Too Far? Towards Medical Therapy for Clinically Nonfunctioning Pituitary Tumors. [PDF]
Mogar N, Zhang D, Heaney AP.
europepmc +1 more source
Cannabinoid exposure during pregnancy: Cardiorespiratory effects and offspring outcomes
Abstract figure legend Prenatal exposure to cannabinoids has been investigated across human and animal studies to understand its impact on physiological development. Evidence suggests that early‐life cannabinoid exposure influence multiple developmental processes, extending beyond neurodevelopmental outcomes to potentially affect placental function ...
Luis Gustavo A. Patrone +1 more
wiley +1 more source
The prospective roles of exosomes in pituitary tumors. [PDF]
Lisiewicz P +3 more
europepmc +1 more source
ABSTRACT Durvalumab plus tremelimumab (Dur/Tre) is the first‐line treatment for unresectable hepatocellular carcinoma (uHCC). Immune‐mediated adverse events (imAEs) are common; however, the impact of specific imAE types on treatment persistence and outcomes remains unclear.
Tomomitsu Matono +53 more
wiley +1 more source
Association of coagulation-related indicators with postoperative venous thromboembolism occurrence in patients with pituitary tumors. [PDF]
Xiang Y, Wu Y, Liu H, Chen Z, Pan J.
europepmc +1 more source

